Heart safety check for new drug ESK-001 in healthy people
NCT ID NCT07378579
First seen Feb 01, 2026 · Last updated May 16, 2026 · Updated 15 times
Summary
This study looked at how the experimental drug ESK-001 affects the heart's electrical activity in 52 healthy adults aged 18 to 55. Participants received ESK-001, a placebo, and moxifloxacin at different times to compare effects. The main goal was to see if ESK-001 causes any changes in heart rhythm, helping ensure the drug is safe before testing in patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Fortrea CRU
Daytona Beach, Florida, 32117, United States
Conditions
Explore the condition pages connected to this study.